pharmaceuticals Article Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells Valentina Corvaglia 1,†, Imène Ait Mohamed Amar 2,†,Véronique Garambois 3, Stéphanie Letast 2, Aurélie Garcin 3,Céline Gongora 3 , Maguy Del Rio 3, Caroline Denevault-Sabourin 2 , Nicolas Joubert 2 , Ivan Huc 1 and Philippe Pourquier 3,* 1 Center for Integrated Protein Science, Department of Pharmacy, Ludwig-Maximilians-Universität, 81377 Munich, Germany;
[email protected] (V.C.);
[email protected] (I.H.) 2 GICC EA7501, Equipe IMT, Université de Tours, 10 Boulevard Tonnellé, F-37032 Tours, France;
[email protected] (I.A.M.A.);
[email protected] (S.L.);
[email protected] (C.D.-S.);
[email protected] (N.J.) 3 Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, F-34298 Montpellier, France;
[email protected] (V.G.);
[email protected] (A.G.);
[email protected] (C.G.);
[email protected] (M.D.R.) * Correspondence:
[email protected]; Tel.: +33-467-613-765; Fax: +33-467-613-787 † V.C. and I.A.M.A. contributed equally. Citation: Corvaglia, V.; Ait Mohamed Amar, I.; Garambois, V.; Abstract: Inhibition of protein–DNA interactions represents an attractive strategy to modulate Letast, S.; Garcin, A.; Gongora, C.; Del essential cellular functions. We reported the synthesis of unique oligoamide-based foldamers that Rio, M.; Denevault-Sabourin, C.; adopt single helical conformations and mimic the negatively charged phosphate moieties of B-DNA.